Welcome to LookChem.com Sign In|Join Free

CAS

  • or

148101-51-3

AC-LYS(FMOC)-OH, also known as N-alpha-Fmoc-N-epsilon-aminocaproic acid-L-lysine, is a chemically synthesized product that plays a crucial role in various biochemistry and biotechnology fields. It is primarily used for solid phase peptide synthesis applications or the synthesis of custom-designed peptides. The "FMOC" in its name refers to the 9-fluorenylmethoxycarbonyl protecting group, which is used to protect the amine functionality of the lysine molecule during the peptide synthesis process. The "AC" stands for aminocaproic acid, while "LYS" refers to lysine, an essential amino acid. This combination makes AC-LYS(FMOC)-OH a vital component in synthesizing or analyzing proteins in medical and biological research. It is a white solid, commercially available product, and is significantly important in pharmaceutical science for the development of numerous drugs.

148101-51-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 148101-51-3 Structure

  • Basic information

    1. Product Name: AC-LYS(FMOC)-OH
    2. Synonyms: AC-LYS(FMOC)-OH;Ac-Lys(Fmoc);N-alpha-Ac-Nε-2-Fmoc-L-lysine
    3. CAS NO:148101-51-3
    4. Molecular Formula: C23H26N2O5
    5. Molecular Weight: 410.46
    6. EINECS: 200-528-9
    7. Product Categories: Amino Acids and Derivatives
    8. Mol File: 148101-51-3.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 709.4±60.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.239±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: 2-8°C
    8. Solubility: N/A
    9. PKA: 3.65±0.10(Predicted)
    10. CAS DataBase Reference: AC-LYS(FMOC)-OH(CAS DataBase Reference)
    11. NIST Chemistry Reference: AC-LYS(FMOC)-OH(148101-51-3)
    12. EPA Substance Registry System: AC-LYS(FMOC)-OH(148101-51-3)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 148101-51-3(Hazardous Substances Data)

148101-51-3 Usage

Uses

Used in Pharmaceutical Science:
AC-LYS(FMOC)-OH is used as a key component in the synthesis of various drugs, contributing to the development of new pharmaceuticals and therapeutics.
Used in Biochemistry and Biotechnology:
AC-LYS(FMOC)-OH is used as a building block in the solid phase peptide synthesis process, allowing for the creation of custom-designed peptides for research and development purposes.
Used in Medical and Biological Research:
AC-LYS(FMOC)-OH is used as a crucial component in the synthesis and analysis of proteins, aiding in the understanding of protein structures and functions, as well as their roles in various biological processes.

Check Digit Verification of cas no

The CAS Registry Mumber 148101-51-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,8,1,0 and 1 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 148101-51:
(8*1)+(7*4)+(6*8)+(5*1)+(4*0)+(3*1)+(2*5)+(1*1)=103
103 % 10 = 3
So 148101-51-3 is a valid CAS Registry Number.

148101-51-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Ac-Lys(Fmoc)-OH

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:148101-51-3 SDS

148101-51-3Relevant articles and documents

SPLICEOSTATIN ANALOGS

-

, (2014/05/24)

The present invention is directed to novel cytotoxic spliceostatin analogs (I) and derivatives, to antibody drug conjugates thereof, and to methods for using the same to treat medical conditions including cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 148101-51-3